Therefore, there is no evidence to support the use of CRP as a tool for the prediction of the presence of MIAC and HCA, and the results suggest that amniocentesis is the most accurate tool for MIAC and HCA prediction in women with PPROM. This evidence concerns the gene CRP and preterm premature rupture of the membranes.